Go Pro
NASDAQ:KEQU

Kewaunee Scientific (KEQU) Stock Price, News & Analysis

Kewaunee Scientific logo
$34.11 -2.00 (-5.54%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$34.94 +0.83 (+2.42%)
As of 09/18/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Kewaunee Scientific Stock (NASDAQ:KEQU)

Advanced

Key Stats

Today's Range
$34.01
$35.50
50-Day Range
$34.11
$38.11
52-Week Range
$32.00
$46.57
Volume
28,762 shs
Average Volume
2,792 shs
Market Capitalization
$98.92 million
P/E Ratio
12.36
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Kewaunee Scientific Corporation designs, manufactures and installs laboratory, healthcare and technical furniture and related products. Its offerings include laboratory casework, steel and wood cabinets, countertops, sinks, storage systems, fume hoods, workstations and other specialized equipment used in research, education, healthcare, industrial and government facilities.

The company provides laboratory planning, design and installation services in addition to its manufactured products, supporting projects ranging from individual laboratory upgrades to larger, turnkey facilities. Its products are marketed through direct sales, distributors, dealers and representatives.

Founded in 1906, Kewaunee Scientific is headquartered in Statesville, North Carolina. The company serves customers in the United States and international markets, including through its operations and business relationships in India and other regions. Its products are used by universities, hospitals, pharmaceutical and biotechnology companies, industrial organizations and government institutions.

AI Generated. May Contain Errors.

Kewaunee Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

KEQU MarketRank™: 

Kewaunee Scientific scored higher than 16% of companies evaluated by MarketBeat, and ranked 818th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Kewaunee Scientific has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Kewaunee Scientific has only been the subject of 1 research reports in the past 90 days.

  • Read more about Kewaunee Scientific's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Kewaunee Scientific is 12.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Kewaunee Scientific is 12.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.49.

  • Price to Book Value per Share Ratio

    Kewaunee Scientific has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.93% of the float of Kewaunee Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Kewaunee Scientific has a short interest ratio ("days to cover") of 24.87, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Kewaunee Scientific has recently increased by 6.77%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Kewaunee Scientific does not currently pay a dividend.

  • Dividend Growth

    Kewaunee Scientific does not have a long track record of dividend growth.

  • News Sentiment

    Kewaunee Scientific has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Kewaunee Scientific this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Kewaunee Scientific insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.10% of the stock of Kewaunee Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    32.69% of the stock of Kewaunee Scientific is held by institutions.

  • Read more about Kewaunee Scientific's insider trading history.
Receive KEQU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kewaunee Scientific and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KEQU Stock News Headlines

Critical Review: Kewaunee Scientific (KEQU) & Its Rivals
Kewaunee Scientific Q1 Sales Fall 6.7% to $66.3 Million
The hidden costs of a hands-off retirement account
Contributing to your 401(k) consistently is good financial behavior - but contributing and optimizing are two different things. High fees, heavy company stock concentration, and target-date funds that follow a formula rather than your situation can quietly erode your balance over time. 74% of U.S. millionaires work with a financial advisor - more than double the general population rate. A fiduciary advisor can review your 401(k) for fees, allocation, and alignment with your actual timeline. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors in their area.tc pixel
Kewaunee Scientific (KEQU) & Its Peers Financial Analysis
See More Headlines

KEQU Stock Analysis - Frequently Asked Questions

Kewaunee Scientific's stock was trading at $37.41 on January 1st, 2026. Since then, KEQU shares have decreased by 8.8% and is now trading at $34.11.

Kewaunee Scientific Corporation (NASDAQ:KEQU) announced its earnings results on Wednesday, September, 9th. The technology company reported $0.58 EPS for the quarter. The technology company earned $66.32 million during the quarter. Kewaunee Scientific had a net margin of 2.97% and a trailing twelve-month return on equity of 11.61%.

Top institutional shareholders of Kewaunee Scientific include Punch & Associates Investment Management Inc. (3.68%), De Lisle Partners LLP (1.83%) and BlackRock Inc. (0.42%). Insiders that own company stock include Thomas David Hull III, John Russell, Keith M Gehl, Ryan S Noble, Donald T Gardner III, Elizabeth D Phillips and Douglas J Batdorff.
View institutional ownership trends
.

Shares of KEQU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kewaunee Scientific investors own include Broadcom (AVGO), NVIDIA (NVDA), e.l.f. Beauty (ELF), Jabil (JBL), Arista Networks (ANET), Adobe (ADBE) and Disc Medicine (IRON).

Company Calendar

Last Earnings
9/09/2026
Today
9/20/2026
Fiscal Year End
4/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:KEQU
CIK
55529
Employees
1,231
Year Founded
1906

Profitability

EPS (Trailing Twelve Months)
$2.76
Trailing P/E Ratio
12.36
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$9.62 million
Net Margins
2.97%
Pretax Margin
4.46%
Return on Equity
11.61%
Return on Assets
4.82%

Debt

Debt-to-Equity Ratio
0.51
Current Ratio
2.20
Quick Ratio
1.55

Sales & Book Value

Annual Sales
$282 million
Price / Sales
0.35
Cash Flow
$5.95 per share
Price / Cash Flow
5.73
Book Value
$26.67 per share
Price / Book
1.28

Miscellaneous

Outstanding Shares
2,900,000
Free Float
2,487,000
Market Cap
$98.92 million
Optionable
Not Optionable
Beta
0.73

Social Links

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:KEQU) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners